Product Revenue, Net was Jaguar Health’s largest revenue line in fiscal 2025, bringing in $11.34M of $11.51M (99%).
| Products and Services | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Product Revenue, Net | $11.74M | $9.76M | $11.56M | $11.34M | ||||||
| Product Revenue | — | — | — | — | ||||||
| Mytesi | — | — | — | — | ||||||
| Neonorm | — | — | — | — | ||||||
| License | — | — | $129.00K | $172.00K | ||||||
| Botanical Extract | — | — | — | — | ||||||
| Total | $11.74M | $9.76M | $11.69M | $11.51M |
Jaguar Health brought in $11.51M from its two revenue lines in fiscal 2025, the year ended December 31, 2025. That was down 1.5% from $11.69M in fiscal 2024. Product Revenue, Net was the largest at $11.34M (98.5%), ahead of License at $172.00K (1.5%).
Jaguar Health began breaking out License in fiscal 2024, when it brought in $129.00K.
Jaguar Health (JAGX) reports its revenue by products and services. In fiscal 2025, Product Revenue, Net was its largest revenue line, bringing in $11.34M (98.5% of the total), followed by License at $172.00K (1.5%).
Product Revenue, Net was Jaguar Health's largest revenue line in fiscal 2025, bringing in $11.34M, or 98.5% of the $11.51M total across its two revenue lines.
Every figure comes from Jaguar Health's annual financial filings, as reported. Each line keeps the name Jaguar Health gives it, and years follow its fiscal calendar.
Jaguar Health's revenue by products and services goes back to fiscal 2016, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.